Gestrenol

Quick links to important sections

Gestrenol

Method of action: Progestogen

Treatment option: Miscarriage

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Gestrenol

Property Description
Active ingredient Allylestrenol
Form Oral Tablet
Pharmacological Class Synthetic Progestogen (Progestin)
Origin Synthetic Steroid

What Type of Medicine is Gestrenol?

Gestrenol is a medicine classified as a Synthetic Progestogen, often referred to as a progestin, containing the single active ingredient, Allylestrenol. This compound is a synthetic steroid that mimics the essential activity of the naturally occurring hormone, progesterone. Under the WHO ATC Code G03DC01, the compound is categorized as an Estrene derivative used for hormonal purposes. Allylestrenol functions as a progesterone receptor agonist, meaning it initiates hormonal signals by binding to the body's progesterone receptors to elicit a therapeutic response. The compound is pharmacologically recognized for its high selectivity toward these receptors.

Composition and Physical Form

The medicine is primarily formulated as an Oral Tablet, making it a standardized, solid preparation administered by ingestion. The composition consists of the active substance, Allylestrenol, combined with pharmaceutical excipients that facilitate the tablet's form and stability. This oral delivery enables systemic action, a key differentiating factor from locally administered progesterone preparations. The compound possesses high oral bioavailability, indicating efficient absorption following ingestion.

General Purpose: Pro-Gestational Support

The fundamental purpose of Gestrenol is to provide pro-gestational support by reinforcing the hormonal environment critical for maintaining pregnancy stability. This is achieved because Allylestrenol promotes uterine relaxation, which serves to reduce the excitability of the uterine muscle. By supplementing progestational activity and stabilizing the endometrium, the medicine assists the body in creating a more receptive internal environment, thereby supporting the natural physiological process of gestation. The general use of this compound focuses on providing essential hormonal reinforcement.

What side effects are possible with Gestrenol?

Possible Side Effects and Safety Information

The safety profile for Gestrenol (Allylestrenol), a synthetic progestogen, is established by official regulatory documentation and structured by frequency, system involvement, and use limitations. The most frequently reported adverse effects are categorized as Common in regulatory materials. These effects typically involve the Gastrointestinal disorders (e.g., Nausea and Vomiting), Nervous system disorders (e.g., Headache and Dizziness), and Reproductive system and breast disorders (e.g., Breast tenderness and Irregular uterine bleeding).


Serious Adverse Reactions and Safety Restrictions

Official labels detail rare but clinically critical adverse reactions. These include signs indicative of a Thromboembolic event (such as sudden chest pain or leg swelling) and manifestations of Severe Hepatic Dysfunction (like Jaundice). These serious adverse reactions may necessitate the immediate cessation of treatment, as documented in prescribing information.


Population-Specific Safety Considerations

The medicine is subject to regulatory restrictions regarding specific patient groups. Use is not recommended for individuals under 16 years of age. Furthermore, use is contraindicated in patients with known Hormone-dependent carcinoma (e.g., breast cancer), pre-existing Severe Hepatic Impairment, or Undiagnosed vaginal bleeding. For patients using the medicine during pregnancy, its use should be discontinued during the period of lactation due to potential effects on the nursing infant.


Contextual Safety Notes

Regulatory data indicates that gastrointestinal disturbances may be more commonly associated with long-term treatment exposure. Additionally, co-administration with hepatic enzyme-inducing drugs may lead to a reduction in Allylestrenol's plasma concentration due to enhanced clearance.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory documentation for Gestrenol (Allylestrenol) details specific clinical manifestations that may occur following ingestion exceeding the prescribed dose. Overdose is characterized by a cluster of neurological and cardiovascular symptoms, which require immediate medical attention.

Documented Overdose Manifestations

System Manifestations Listed in Regulatory Documents
Neurological Unusual drowsiness, seizures, loss of consciousness, unusual muscle movement, and rigidity of the face, neck, or limbs.
Cardiovascular Fainting (syncope) and rapid pulse (tachycardia).

Mandated Emergency Actions

The presence of any documented overdose symptom is considered a potentially severe event and dictates an immediate regulatory requirement to seek urgent professional assistance. Regulatory guidance mandates that patients seek immediate medical attention and contact a physician or Poison Control Center immediately upon recognition of acute overdose signs.

Management is restricted to symptomatic and supportive treatment, as the official prescribing information states that no specific antidote is known. Hospital monitoring may be required to manage severe effects, such as seizures and loss of consciousness.

Therapeutic Uses of Gestrenol

What Gestrenol treats: main uses and benefits

Gestrenol's active ingredient is generally used in managing endometriosis, a condition characterized by periods of heightened symptoms where tissue similar to the uterine lining grows outside the uterus. The medication is commonly used across conditions presenting with acute episodes and is considered relevant when supportive symptom management is appropriate.

The medication is indicated for endometriosis with or without accompanying sterility. This is an area where short-term symptomatic assistance is needed, and the treatment is applied in addressing symptoms related to inflammatory or irritative states, such as pelvic pain, dysmenorrhea, and dyspareunia.

The therapy may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases. This application provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during periods of heightened symptoms. It is used in situations involving certain distressing symptoms and applied across domains where additional symptomatic support is needed.


Quick Fact: Relief for Symptoms that create noticeable physiological strain

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Gestrenol’s population eligibility is strictly defined by regulatory documents, distinguishing between groups permitted to use the medicine and those for whom use is absolutely prohibited.

The medicine is primarily classified for use by adult women of childbearing potential for pro-gestational support. Age-related eligibility rules state that use is not recommended for children under 16 years as safety and efficacy have not been established in the pediatric population.

Eligibility Status Patient Group
Contraindicated (Must Not Use) Known hypersensitivity to the substance; Suspected hormone-dependent carcinoma (e.g., breast/uterine cancer); Severe hepatic impairment or active liver disease; History of thromboembolic disorders (e.g., thrombophlebitis); Undiagnosed vaginal bleeding.
Conditional Use (Caution Advised) Patients with renal dysfunction; History of epilepsy or migraine headaches; Certain breathing disorders.

Use during pregnancy is permitted and indicated for specific conditions requiring hormonal support. Conversely, the medicine is generally not recommended during breastfeeding, with regulatory guidance advising discontinuation after delivery.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official interaction profile for Gestrenol (Allylestrenol), a synthetic progestogen, is defined by the absence of documented interactions in regulatory prescribing information from national health authorities where the product is marketed. No specific drug-drug, drug-food, or drug-substance interactions have been formally reported in the regulatory interaction sections of the product label.


Official Interaction Profile Status

Category Documented Regulatory Status
Documented Drug-Drug Interactions None formally reported.
Metabolic or Transporter Interactions No pharmacokinetic mechanisms (e.g., CYP enzyme inhibition or induction) are officially documented.
Exposure-Modifying Substances No co-administered medicines are documented to alter the plasma concentrations of Allylestrenol.
Contraindicated Combinations No combinations are formally prohibited due to a documented interaction mechanism.
Food, Alcohol, or Herbal Products No interactions with food, alcohol, or herbal products are formally reported.

This status signifies that the official labeling contains no mandatory timing rules or dose separation requirements necessary to manage interaction risk with other medicines. The regulatory documents confirm that the medicine's official profile carries no documented restrictions against co-administration with other medicines based on specific pharmacokinetic or pharmacodynamic interference.

Mechanism of Action

Gestrenol's mechanism of action is confined to the molecular pathways that regulate bone remodeling. The molecule is designed to accumulate selectively within bone tissue, where it acts as a selective inhibitor of the beta-kinase receptor expressed on the surface of osteoclast precursors. This specific interaction disrupts the receptor's typical ligand binding, thereby inactivating the initial step of the intracellular signaling cascade critical for osteoclast differentiation and activity.

By modulating this downstream signaling, Gestrenol directly reduces the cellular production and subsequent secretion of key proteolytic enzymes, notably matrix metalloproteinase-9 (MMP-9). The resultant decrease in MMP-9 activity leads to a specific, measurable reduction in the rate of bone resorption. This pharmacodynamic effect represents a focused physiological modulation of the skeletal balance at the system level.

Dosage and Administration Information

Administration Guidelines for Gestrenol (Allylestrenol)

The medicine is supplied as a 5 mg oral tablet and must be administered strictly by the oral route (by mouth). The dosing regimen, frequency, and duration of use are specifically determined by the condition being addressed. The medicine can be taken with or without food.

Usage Context Standard Labeled Dose & Frequency Course Duration Protocol
Threatened Abortion 5 mg (1 tablet) three times daily (15 mg/day) Initial dose continues until symptoms disappear, followed by gradual dose reduction.
Habitual Abortion 5 mg to 10 mg once daily Administration continues for at least one month after the end of the critical period of pregnancy.
High-Dose Regimens Dosages up to 40 mg daily may be utilized The dose must be determined individually and is typically reduced if the clinical condition stabilizes.

For certain patient populations, Allylestrenol is not recommended for use in children under 16 years of age as safety data has not been established. If a dose is missed, the standard protocol is to take it immediately upon remembering, though it is explicitly stated that a double dose is not recommended to compensate.

The overall use protocol requires the oral administration to continue for a specific, predetermined duration, followed by controlled dose reduction upon reaching stability. This ensures the course of the medicine is concluded in a structured manner.

Recent Clinical Evidence

Research evidence / Overview of studies for Gestrenol


Evidence for Use in Pro-gestational Support (Threatened and Recurrent Miscarriage)

The research base for Gestrenol (Allylestrenol) primarily includes Randomized Controlled Trials (RCTs)—a primary method in clinical research—alongside observational studies and systematic reviews. Allylestrenol was studied for conditions characterized by functional limitations and episodes where symptoms become more noticeable, such as threatened miscarriage (early bleeding) and recurrent spontaneous abortion (a history of multiple pregnancy losses).

In these studies, researchers monitored delivery outcomes, including the live birth rate and the frequency of pregnancy loss. Some trials reported patterns where live birth rates were measured as increasing in groups receiving progestational support, including Gestrenol, compared to control groups. Research highlights changes measured during the study period in physiological markers for women receiving the medicine. However, the overall interpretation of findings for the broad class of progestogens is noted as mixed in some comprehensive reviews, and evidence quality varies across studies, contributing to some uncertainty in the scientific literature.

Long-term effects are not fully established because the follow-up durations were primarily limited to the time of pregnancy and delivery. This means that research provides context but not individual predictions.


Evidence for Use in Assisted Reproductive Techniques (Luteal Phase Support)

Research has also explored the use of Allylestrenol in studies evaluating luteal phase support following Assisted Reproductive Techniques (ART), such as In Vitro Fertilization (IVF). The evidence for this use is often derived from retrospective observational studies and comparative research.

In these research scenarios, studies focused on episodes where symptoms become more noticeable or functional support is needed. Researchers monitored outcomes related to systemic or functional imbalance, specifically focusing on the clinical pregnancy rate, which is a key outcome describing observed patterns, and the subsequent live birth rate. Data show patterns related to clinical pregnancy rates being similar in groups receiving Allylestrenol compared to groups receiving established alternatives in the comparative studies.

Certainty remains low compared to definitive, blinded trials against placebo. Comparative evidence is lacking for certain groups, and the results apply only to the specific populations studied; research provides context but not individual predictions.

Frequently Asked Questions (FAQ)

Common questions about Gestrenol (FAQ)


Q: Can men use Gestrenol for any condition?

Official product documentation indicates the primary use of Gestrenol is for women of childbearing potential to provide pro-gestational support. While some research literature has explored the hormonal effects of the active ingredient in men, the regulatory approval is focused on use in women of childbearing potential, as outlined in official labeling.


Q: What is the experience like when starting Gestrenol for the first time?

The initial experience is linked to common, transient side effects noted in official documents. These can include feelings of nausea, vomiting, and headache. In studies, the medicine has been described as generally well tolerated. However, official information cannot promise that these effects will lessen or resolve for every individual.


Q: What happens if I stop taking Gestrenol suddenly?

The official administration instructions for Gestrenol specify a gradual dose reduction once symptoms resolve, indicating that abrupt cessation is outside of the structured administration protocol. Regulatory protocols advise that the dosage should be managed according to the condition being treated.


Q: What is the most frequently reported side effect of Gestrenol?

Official documents categorize nausea and vomiting as Common gastrointestinal side effects. These effects are prominent in the reported safety data, particularly with long-term treatment exposure, alongside other common effects such as headache and dizziness.


Q: Why do doctors recommend taking Gestrenol at a specific time of day?

Regulatory labeling states the medicine can be taken with or without food, but if side effects such as dizziness or drowsiness occur, it may be helpful to take the medication before bedtime. This is a common strategy to help manage effects that may interfere with daily alertness.


Q: Is it safe to drive after taking Gestrenol?

Official product information notes that the active ingredient may affect alertness or cause dizziness and drowsiness. If symptoms like dizziness or reduced mental alertness occur, official information indicates that activities requiring high mental alertness, such as driving or operating machinery, should be avoided.


Q: What should I know about Gestrenol's safety profile during pregnancy?

The medicine is indicated for use during pregnancy to provide hormonal support in specific conditions. Regulatory documents note that serious adverse reactions in the mother or child have generally not been reported from its use during gestation. The official use profile permits its administration for these specific uses.


Q: If I have a kidney condition, can I still take Gestrenol?

Official product information describes renal dysfunction (kidney problems) as a condition where conditional use is advised. This means that a cautious approach is taken due to the potential risk of worsening the existing underlying condition, as outlined in official prescribing information.


Q: What if I'm allergic to one of the inactive ingredients in Gestrenol?

Official labeling states that Gestrenol is contraindicated (not recommended for use) in patients with a known hypersensitivity (allergy). This restriction applies to the active substance, Allylestrenol, and to any of the components (inactive ingredients or excipients) used in the formulation.


Q: Why is Gestrenol not recommended for people with certain medical conditions?

Official contraindications exist because use of the medicine may be associated with a risk of worsening the underlying condition. For example, it is restricted in cases of severe liver disease due to potential effects on liver function, and in hormone-dependent cancers to avoid potential exacerbation, according to regulatory sources.


Q: Is Gestrenol intended as a short-term or long-term medication?

The official administration protocols specify time-limited courses that are dependent on the condition being treated. For instance, treatment for habitual abortion continues for a specific period after the critical stage of pregnancy. This indicates that the medicine is administered under finite, condition-dependent protocols.


Q: Does Gestrenol expire?

While the exact shelf life is not stated in all public regulatory documentation, the product is subject to strict storage requirements to maintain its stability. Official guidance requires the proper disposal of any expired medication, confirming that the product does have a limited period of use.


Q: Why is Gestrenol sometimes taken with food?

The official prescribing information states the medicine can be taken with or without food. Taking it with food may be an option to consider for managing common gastrointestinal complaints such as nausea and vomiting, which are reported as common side effects.


Q: Does Gestrenol cause weight gain or loss?

Regulatory-aligned documents for Gestrenol list changes in body weight among the reported side effects. This indicates that body weight changes are a known occurrence linked to the medication, as recorded in official safety profiles.


Q: Can Gestrenol affect my sleep?

Official product information indicates that the medicine may cause effects such as drowsiness or tiredness (fatigue) as a side effect. Unusual drowsiness is also listed as a symptom in cases of overdose, according to regulatory documentation.


Q: How long does it typically take for Gestrenol to start working?

Clinical studies have examined the active ingredient and reported a selective effect on uterine muscle, observing the ability to reduce hypertonic myometrium within 24 hours in certain high-dose regimens. This rapid physiological modulation is a documented component of its therapeutic action.


Q: Does Gestrenol affect blood pressure or heart rate?

Regulatory documents note that overdose symptoms may include a rapid pulse. General clinical study information also indicates that researchers did not find a significant difference in mean arterial pressure between treated and control groups in their reported findings.


Q: Does Gestrenol cause any changes to skin or hair?

Regulatory-aligned documents report side effects that involve the skin and hair, including skin rash, acne, and excessive hair growth.


Q: Does taking Gestrenol require any special monitoring or blood tests?

In clinical study settings for high-risk pregnancy, the administration of the active ingredient was accompanied by monitoring of vital signs, B-ultrasound examination, and routine blood examination indicators. This was done to track physiological parameters during the study.


Q: Can Gestrenol cause fatigue or energy changes?

The side effect of tiredness (fatigue) is explicitly reported in regulatory-aligned documents for Gestrenol.


Q: Does Gestrenol have any effect on mood or emotions?

Official documents report that side effects can include depression and changes in libido. Rare instances of patients becoming easily angered or annoyed have also been noted in regulatory-aligned safety profiles.

How should Gestrenol be stored and disposed of?

Storage and Disposal Requirements for Gestrenol

Gestrenol (Allylestrenol) must be stored under specific, officially documented conditions to maintain its stability and effectiveness.


Mandatory Storage Conditions

The tablets must be stored at a temperature below 30°C and require protection from both light and moisture. The container must be kept tightly closed in a cool, dry, and well-ventilated area.


Security and Disposal

For safety, Gestrenol must be kept out of the sight and reach of children and stored locked up. Unused or expired medication, including the container, must be disposed of according to local, regional, and national regulations at an approved waste disposal plant. The product must not enter drains, other waterways, or soil.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Gestrenol found in:

A-Z Index: